ClinicalTrials.Veeva

Menu
Celerion | Lincoln Celerion CPU logo

Celerion | Lincoln Celerion CPU

Research site

Site insights

Top conditions

Top treatments

MK-0616
Enlicitide Decanoate
Itraconazole
Islatravir
MK-1084
Nicotine
Entinostat
TAK-831
IkT-148009
Midazolam

Parent organization

This site is a part of Celerion

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

9 of 165 total trials

A Clinical Study of the Effect of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-041)

The goal of this study is to learn what happens to enlicitide (MK-0616) in a healthy person's body over time (pharmacokinetic or PK study). Researche...

Active, not recruiting
Healthy
Drug: Enlicitide

The goal of this clinical trial is to learn if BLKR201 is safe in healthy adults. Researchers will also learn how the body absorbs and processes BLKR...

Begins enrollment this month
Healthy
Drug: Placebo
Drug: BLKR201

Characterize the safety, tolerability and pharmacokinetics of ORX489 following single and multiple doses.

Enrolling
Healthy Adult Male and Female Volunteers
Drug: ORX489 Tablets
Other: Placebo Tablets

The purpose of the present trial is to obtain information on the absorption, distribution, metabolism, excretion and pharmacokinetics (PK) of 14C-SEP...

Not yet enrolling
Schizophrenia
Drug: 14C-SEP-380135

This study will be conducted to evaluate the effect of food on the single-dose pharmacokinetics and a drug-drug interaction evaluation of itraconazol...

Enrolling
Healthy Participants
Drug: itraconazole
Drug: INCB123667

This is a first-in-human study to evaluate safety and tolerability, pharmacokinetics, and pharmacodynamics of single and multiple dose levels of KT-5...

Enrolling
Healthy Participants
Drug: KT-579
Drug: Placebo

The purpose of the study is to investigate the routes of elimination and overall mass balance of 100 mg quemliclustat containing 75 μCi \[14C\] follo...

Active, not recruiting
Healthy Participants
Drug: Quemliclustat

This first-in-human study is a randomized, double-blind, placebo-controlled, single-ascending dose and multiple-ascending dose study of SL-325 in hea...

Enrolling
Healthy Volunteers
Biological: SL-325
Other: Placebo (Normal Saline)

This is a multiple part, multiple cohort study evaluating the relative bioavailability, food effect, and drug-drug interaction of NX-5948 in healthy...

Enrolling
Healthy Volunteer
Drug: Esomeprazole
Drug: NX-5948

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Takeda logo
Theravance Biopharma logo
Incyte logo
Janssen (J&J Innovative Medicine) logo
Arcus Biosciences logo
Bridge Biotherapeutics logo
Edgewise Therapeutics logo
G
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems